CIO
APRIL 17, 2024
While this example offers a peek at how productivity gains can be achieved in software development, what’s even more interesting is how tech companies, including Planview, are jockeying for competitive advantage in what they bring to market. Some will probably sell a service where they adapt open models to specific problems.”
Alpha Sense BI
FEBRUARY 8, 2023
Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Netbasequid
FEBRUARY 22, 2021
In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” Want to know how many biotech companies have received private funding over the last ten years?
Alpha Sense BI
JANUARY 25, 2023
Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.
Alpha Sense BI
AUGUST 30, 2023
As time goes on and more firms adopt AI tools, these capabilities will become even more essential to maintain a competitive advantage. The AI Advantage It’s clear that AI is here to stay, and the time is now for firms to get on board with this technology.
Evalueserve
DECEMBER 6, 2021
On the other hand, Biotech heavily underperformed post Q1’21 primarily due to the shifting of focus towards cyclicals and negative sentiments arising as of result of greater regulatory clampdown on transformative deals and drug pricing. These companies will be able to reshape the competitive landscape of the pharmaceutical industry.
Alpha Sense BI
MAY 5, 2023
Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.
Expert insights. Personalized for you.
730 
Let's personalize your content